← Open Payments lookup

DOUGLAS BYRD: Open Payments

NPI 1477679736 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 30 payments from 10 companies in 2025. Trend: 2023 $1,222 · 2024 $716 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
ABBVIE INC.15$219
Vanda Pharmaceuticals Inc.4$111
Takeda Pharmaceuticals U.S.A., Inc.2$43
Corium, LLC2$40
Otsuka America Pharmaceutical, Inc.2$40
Axsome Therapeutics, Inc.1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Otsuka Pharmaceutical Development & Commercialization, Inc.1$18
Supernus Pharmaceuticals, Inc.1$14
Teva Pharmaceuticals USA, Inc.1$14

Products named: VRAYLAR, FANAPT, TRINTELLIX, Azstarys, REXULTI, Auvelity, CAPLYTA, Qelbree.

Industry payments across MS — which companies pay providers there.